
FDA Approves First Human Trial For HIV Cure
The first-in-human clinical study for a prospective treatment for people living with human immunodeficiency virus type 1 will begin soon after its developer, Excision BioTherapeutics, got FDA approval as an Investigational New Drug today (FDA). The FDA’s IND authorization clears the way for first Phase I/II trial to assess EBT-101 as a potential cure for